Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lung

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 1, 2010, Pages 60-70

  Ungaro, Francesca ^a   Giovino, Concetta ^a   Coletta, Ciro ^a   Sorrentino, Raffaella ^a   Miro, Agnese ^a   Quaglia, Fabiana ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Large porous particles; Macromolecules; Phospholipids; PLGA; Pulmonary delivery

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; AMMONIA; AMMONIUM BICARBONATE; AMMONIUM DERIVATIVE; CARBON DIOXIDE; DEXTRAN; DIPALMITOYLPHOSPHATIDYLCHOLINE; ISOTHIOCYANIC ACID DERIVATIVE; POLYGLACTIN; RHODAMINE B; SOLVENT; UNCLASSIFIED DRUG; DRUG CARRIER; GAS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRICITY; EMULSION; EVAPORATION; HYDROPHILICITY; MACROMOLECULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; GAS; LUNG; METABOLISM; WISTAR RAT;

ANIMALS; DRUG CARRIERS; GASES; LUNG; MALE; RATS; RATS, WISTAR;

EID: 77954759958     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.05.011     Document Type: Article

References (39)

1. Agu R.U., Ugwoke M.I., Armand M., Kinget R., Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2001, 2:198-209.
2. Allison S.D. Analysis of initial burst in PLGA microparticles. Expert Opin. Drug Deliv. 2008, 5:615-628.
3. Batycky R.P., Hanes J., Langer R., Edwards D.A. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 1997, 86:1464-1474.
4. Cryan S.A. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J. 2005, 7:E20-E41.
5. Densmore C.L. Advances in noninvasive pulmonary gene therapy. Curr. Drug Deliv. 2006, 3:55-63.
6. De Rosa G., Quaglia F., Bochot A., Ungaro F., Fattal E. Long term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres. Biomacromolecules 2003, 4:529-536.
7. De Rosa G., La Rotonda M.I., Quaglia F., Ungaro F. Use of additives in the design of poly(lactide-co-glycolide) microspheres for drug delivery. Handbook of Particulate Drug Delivery 2008, 61-91. American Scientific Publisher, CA, USA. M.N.V. Ravi Kumar (Ed.).
8. Díez S., Navarro G., de Ilarduya C.T. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma. J. Gene Med. 2009, 11:38-45.
9. Edwards D.A., Ben Jebria A., Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 1998, 85:379-385.
10. Evora C., Soriano I., Rogers R.A., Shakesheff K.N., Hanes J., Langer R. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J. Control. Release 1998, 51:143-152.
11. Frijlink H.W., De Boer A.H. Dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 2004, 1:67-86.
12. Garbuzenko O.B., Saad M., Betigeri S., Zhang M., Vetcher A.A., Soldatenkov V.A., Reimer D.C., Pozharov V.P., Minko T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharm. Res. 2009, 26:382-394.
13. Kaye R.S., Purewal T.S., Alpar H.O. Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. J. Pharm. Sci. 2009, 98:4055-4068.
14. Kim T.K., Yoon J.J., Lee D.S., Park T.G. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 2006, 27:152-159.
15. Kleinstreuer C., Zhang Z., Donohue J.F. Targeted drug-aerosol delivery in the human respiratory system. Annu. Rev. Biomed. Eng. 2008, 10:195-220.
16. Know M.J., Bae J.H., Kim J.J., Na K., Lee E.S. Long acting porous microparticles for pulmonary protein delivery. Int. J. Pharm. 2007, 333:5-9.
17. Koushik K., Dhanda D.S., Cheruvu N.P., Kompella U.B. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm. Res. 2004, 21:1119-1126.
18. Kumar T.R., Soppimath K., Nachaegari S.K. Novel delivery technologies for protein and peptide therapeutics. Curr. Pharm. Biotechnol. 2006, 7:261-276.
19. Laube B.L. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir. Care 2005, 50:1161-1176.
20. Lemaire V., Bélair J., Hildgen P. Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process. Int. J. Pharm. 2003, 258:95-107.
21. Meakin B.J., Woodcock P.M., Segu A., Niccolai F., Vecchio C. Evaluation of the resistance to airflow through Turbospin in comparison with dry powder inhalers available on the market. Boll. Chim. Farm.-Anno 1996, 135(125):107-109.
22. Minne A., Boireau H., Horta M.J., Vanbever R. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Eur. J. Pharm. Biopharm. 2008, 70:839-844.
23. Mohamed F., van der Walle C.F. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J. Pharm. Sci. 2008, 97:71-87.
24. Moschos S.A., Spinks K., Williams A.E., Lindsay M.A. Targeting the lung using siRNA and antisense based oligonucleotides. Curr. Pharm. Des. 2008, 14:3620-3627.
25. Newhouse M.T., Hirst P.H., Duddu S.P., Walter Y.H., Tarara T.E., Clark A.R., Weers J.G. Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers. Chest 2003, 124:360-366.
26. Newman S.P., Busse W.W. Evolution of dry powder inhaler design, formulation, and performance. Respir. Med. 2002, 96:293-304.
27. Patton J.S., Byron P.R. Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 2007, 6:67-74.
28. Peek L.J., Roberts L., Berkland C. Poly(d,l-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins. Langmuir 2008, 24:9775-9783.
29. Pistel K.F., Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J. Microencapsul. 2000, 17:467-483.
30. Rawat A., Majumder Q.H., Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J. Control. Release 2008, 128:224-232.
31. Séguin R.M., Ferrari N. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease. Expert Opin. Investig. Drugs 2009, 18:1505-1517.
32. Simberg D., Weisman S., Talmon Y., Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit. Rev. Ther. Drug Carrier Syst. 2004, 21:257-317.
33. Taki M., Marriott C., Zeng X.M., Martin G.P. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors. Int. J. Pharm. 2010, 388:40-51.
34. Tsapis N., Bennett D., Jackson B., Weitz D.A., Edwards D.A. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12001-12005.
35. Ungaro F., De Rosa G., Miro A., Quaglia F., La Rotonda M.I. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 2006, 28:423-432.
36. Ungaro F., d'Emmanuele di Villa Bianca R., Giovino C., Miro A., Sorrentino R., Quaglia F., La Rotonda M.I. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release 2009, 135:25-34.
37. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., Edwards D.A. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 1999, 16:1735-1742.
38. Van Campen L., Venthoye G. Inhalation, dry powder. Encyclopedia of Pharmaceutical Technology 2002, 1529-1544. Marcel Dekker Inc., New York. J. Swarbrick, J.C. Boylan (Eds.).
39. Yang Y., Bajai N., Xu P., Ohn K., Tsifansky D., Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009, 30:1-7.